Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 292.95
-0.65 (-0.22%)
May 29, 2026, 4:59 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.3 trillion as of May 29, 2026. Its market cap has decreased by -34.38% in one year.
Market Cap
1.30T
Enterprise Value
1.43T
Revenue
327.80B
Ranking
n/a
PE Ratio
10.71
Stock Price
292.95
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.30T, an increase of 2,729.18%. That is a compound annual growth rate of 12.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 1.30T | -9.95% |
| Dec 30, 2025 | 1.45T | -47.87% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 105.84B |
| Coloplast | 91.17B |
| ALK-Abelló | 58.94B |
| Demant | 51.88B |
| H. Lundbeck | 41.11B |
| Zealand Pharma | 22.67B |
| Ambu A/S | 17.69B |
| Bavarian Nordic | 14.66B |